Variables | All (n = 1225) | TyG ≤ 8.87 (n = 774) | TyG > 8.87 (n = 451) | P-value |
---|---|---|---|---|
General conditions | ||||
 Age (years) | 62.79 ± 8.18 | 63.16 ± 8.22 | 62.12 ± 8.08 | 0.032 |
 Male, n (%) | 857 (70.0) | 569 (73.5) | 288 (63.9) | < 0.001 |
 BMI (kg/m2) | 25.67 ± 3.58 | 25.42 ± 3.64 | 26.11 ± 3.43 | 0.001 |
 LVEF (%) | 58.12 ± 10.52 | 58.46 ± 10.30 | 57.54 ± 10.88 | 0.142 |
 Previous MI, n (%) | 259 (21.1) | 154 (19.9) | 105 (23.3) | 0.162 |
 Previous stroke, n (%) | 185 (15.1) | 104 (13.4) | 81 (18.0) | 0.033 |
 Previous PCI, n (%) | 122 (10.0) | 80 (10.3) | 42 (9.3) | 0.564 |
 Left main disease, n (%) | 282 (23.0) | 171 (22.1) | 111 (24.6) | 0.312 |
 Multivessel disease, n (%) | 1147 (93.6) | 710 (91.7) | 437 (96.9) | < 0.001 |
Risk factors, n (%) | ||||
 Current smoking | 339 (27.7) | 207 (26.7) | 132 (29.3) | 0.341 |
 Current drinking | 316 (25.8) | 199 (25.7) | 117 (25.9) | 0.929 |
 FH-CHD | 247 (20.2) | 145 (18.7) | 102 (22.6) | 0.102 |
 DM | 395 (32.2) | 164 (21.2) | 231 (51.2) | < 0.001 |
 Hypertension | 767 (62.6) | 451 (58.3) | 316 (70.1) | < 0.001 |
 Hyperlipidemia | 394 (32.2) | 215 (27.8) | 179 (39.7) | < 0.001 |
Surgical procedure | ||||
 Duration of surgery (min) | 270.00 (240.00–310.00) | 270.00 (240.00–306.25) | 270.00 (240.00–315.00) | 0.425 |
 OPCABG, n (%) | 139 (11.3) | 75 (9.7) | 64 (14.2) | 0.017 |
 Number of grafts | 3.60 ± 0.98 | 3.56 ± 0.99 | 3.65 ± 0.96 | 0.134 |
 Use of arterial grafts, n (%) | 1171 (95.6) | 738 (95.3) | 433 (96.0) | 0.587 |
Laboratory tests | ||||
 FPG (mmol/L) | 5.41 (4.77–6.84) | 4.99 (4.56–5.66) | 6.97 (5.57–9.20) | < 0.001 |
 TC (mmol/L) | 4.10 (3.48–4.96) | 3.90 (3.30–4.62) | 4.56 (3.78–5.18) | < 0.001 |
 TG (mmol/L) | 1.32 (0.99–1.77) | 1.08 (0.86–1.34) | 1.95 (1.56–2.60) | < 0.001 |
 LDL-C (mmol/L) | 2.45 (1.92–3.04) | 2.36 (1.85–2.86) | 2.66 (2.13–3.34) | < 0.001 |
 HDL-C (mmol/L) | 1.12 ± 0.26 | 1.14 ± 0.27 | 1.08 ± 0.24 | < 0.001 |
 eGFR (mL/min/1.73 m2) | 107.38 ± 29.59 | 107.42 ± 31.04 | 107.40 ± 26.97 | 0.990 |
 SUA (μmol/L) | 307.00 (258.50–372.00) | 304.00 (257.00–363.00) | 317.00 (262.00–383.00) | 0.013 |
Medications at the time of discharge, n (%) | ||||
 Antiplatelet drugs | 1214 (99.1) | 768 (99.2) | 446 (98.9) | 0.777 |
 Statins | 1023 (83.5) | 652 (84.2) | 371 (82.3) | 0.369 |
 Fibrates | 83 (6.8) | 38 (4.9) | 45 (10.0) | 0.001 |
 Hypoglycemic drugs | 285 (23.3) | 117 (15.1) | 168 (37.3) | < 0.001 |
 Urate-lowering drugs | 14 (1.1) | 7 (0.9) | 7 (1.6) | 0.304 |
EuroSCORE II | 1.45 (1.00–2.41) | 1.43 (1.00–2.44) | 1.47 (0.99–2.36) | 0.822 |
MACE, n (%) | 263 (21.5) | 118 (15.2) | 145 (32.2) | < 0.001 |